March 26, 2024—Gestalt Diagnostics announce the launch of its AI Algorithm Evaluator, a new tool within the company’s PathFlow digital pathology platform.
Read More »ARUP chooses Gestalt’s PathFlow for digital pathology
April 13, 2023—ARUP Laboratories has selected Gestalt Diagnostics’ PathFlow digital platform to support its vision, ARUP says, for digital pathology.
Read More »Newsbytes
November 2022—Bias—a type of prejudice that may go back to the beginning of humankind—has, in recent years, been the focus of attention with regard to developing machine-learning algorithms for clinical laboratory testing.
Read More »mTuitive, Gestalt partner to enhance pathology reporting
Oct. 11, 2022—mTuitive and Gestalt Diagnostics announced a partnership to enhance reporting for pathology laboratories.
Read More »Newsbytes
September 2022—Do you want to play a role in solving a problem or improving a process in your laboratory via machine learning or artificial intelligence but don’t know where to begin? If so, take some time to learn, listen, share, and, perhaps, have a cup of coffee, says Scott Doyle, PhD, biomedical engineer at the State University of New York at Buffalo.
Read More »Newsbytes
August 2022—Transfusion medicine specialists at Phoenix Children’s Hospital may be used to trending laboratory biomarkers for sickle cell disease patients in their heads, but a dashboard supporting red blood cell exchange procedures for such patients eases the burden on their cerebral cortices.
Read More »Intermountain selects Gestalt, Hamamatsu for digital pathology
June 10, 2022—Intermountain Healthcare has chosen Gestalt Diagnostics and Hamamatsu Photonics to implement digital pathology across its health care system.
Read More »Newsbytes
Francisco Partners to acquire Orchard Software
November 2019—Francisco Partners, a technology-focused private equity firm, announced Sept. 30 its intent to acquire Orchard Software. CAP TODAY publisher Bob McGonnagle, on Oct. 2, spoke with Orchard founder and CEO Rob Bush and with Billie Whitehurst, who will succeed Bush as CEO. Whitehurst most recently was senior vice president at Netsmart. Here is what they, and Curt Johnson and Kerry Foster, of Orchard, had to say about the acquisition.
Newsbytes
Building a lab or modernizing? Don’t forget the following March 2019—Building a new pathology lab or revamping an existing one gives laboratory decision-makers an opportunity to rethink information technology infrastructure and address persistent problems, plan for new technology, and improve processes.
Read More »